A precise and non-toxic treatment that targets lung cancer cells at the nanoscale is able to effectively kill the cells even at a low dose.
Researchers from Washington State University and the Department of Energy’s Pacific Northwest National Laboratory (PNNL) used tiny tubes made from organic molecules called peptoids to deliver cancer-killing drugs in a targeted manner. The research, led by Yuehe Lin, professor in WSU’s School of Mechanical and Materials Engineering, and Chun-Long Chen, a senior research scientist at PNNL and a joint faculty fellow at the University of Washington, was published as the cover story in the prestigious journal Small.
The biologically-inspired nanotubes, which are about a hundred thousand times thinner than a human hair, were rolled up from membrane-like nanosheets. The drug molecules, fluorescent dyes and cancer-targeting molecules were precisely placed within the nanotubes, enabling them to track the efficiency of drug delivery into the cancer cells.
The new technology allows the two drugs – one for chemotherapy and the other for a less-invasive photodynamic therapy treatment – to be delivered directly to the cancer cells. Photodynamic therapy uses a chemical that, when exposed to light, releases reactive oxygen species (ROS) that kill cancer cells. The researchers’ dual-drug approach enabled the use of a lower dose of the cancer drugs than using a single drug, leading to effective killing of cancer cells with low toxicity.
“By precisely engineering these nanotubes with fluorescent dyes and cancer targeting molecules, scientists can clearly locate tumor cells and track how the drug regimen is performing,” said Lin. “We can also track how nanotubes enter and deliver the drugs inside the cancer cell.”
The team tested the nanotubes on lung cancer cells and found that they delivered the chemotherapy drug doxorubicin directly into the fast-dividing cancer cells, resulting in highly efficient cancer killing while using less chemotherapy drugs.
“This is a promising approach for precision targeting with little damage to healthy surrounding cells,” said Lin.
While other nanomaterials, such as carbon nanotubes, have been used to deliver and track cancer-killing drugs, researchers have found that they are toxic to the body. Furthermore, they didn’t do well at precisely recognizing molecules.
“By using these peptoids, we were able to develop highly programmable nanotubes and a biocompatible delivery mechanism,” said Chen. “We also harnessed the high stability of peptoid and its well-controlled packing to develop nanotubes that are highly stable.”
“Due to their unique structure, these nanotubes can be easily assembled for use in cancer therapy and stay in the body longer for treatment,” said Lin.
The team is now looking for collaboration and funding opportunities with pharmaceutical companies to extend the research into animal and clinical studies.
Learn more: New drug-delivery technology promises efficient, targeted cancer treatment
The Latest on: Lung cancer
[google_news title=”” keyword=”lung cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Lung cancer
- Imfinzi Boosts Lung Cancer Outcomes, But Some Patients Are Not Given the Drugon May 14, 2024 at 12:00 pm
Imfinzi should be standard of care for post-chemoradiotherapy non-small cell lung cancer treatment, but some patients are not getting the drug, a study found.
- Lawmaker accuses Amgen of placing profits above patients with dosing for a cancer drugon May 14, 2024 at 11:52 am
A U.S. lawmaker is accusing Amgen of “putting profits before patients” over its decision to continue marketing a high dose of a pricey cancer treatment.
- Chicago police captain undergoes ‘lifesaving’ double lung transplant after lung cancer, COVID-19 diagnoseson May 14, 2024 at 10:03 am
A Chicago police captain underwent a successful double lung transplant after being diagnosed with lung cancer and COVID-19 four years ago.
- Double-lung transplant by Northwestern team saves life of Chicagoan hit by COVID-19, canceron May 13, 2024 at 5:56 pm
In January, doctors successfully performed lung surgery on Arthur "Art" Gillespie. Doctors said it was the first double-lung transplant at Northwestern on a set of lungs that had been independently ...
- Lung cancer mystery: Why are healthy, non-smoking, Asian women contracting the disease?on May 13, 2024 at 2:40 pm
A Bay Area-based study finds that 80% of Asian American women with lung cancer never smoked and researchers are trying to figure out why.
- Lung Cancer Warning Signs: What To Look Out Foron May 13, 2024 at 2:28 pm
Overview Cancer which begins in the cells of the lung. It causes difficulty breathing, coughing up blood, chest pain, hoarseness, headache and weight loss. Symptoms If you're experiencing new, severe, ...
- Labour MP Chris Bryant being treated after skin cancer detected in his lungon May 13, 2024 at 11:32 am
Minister, who had treatment for condition five years ago, says melanoma was found during routine scan in January ...
- Chicago Cop with Cancer in One Lung, COVID Damage in the Other Gets Successful Double Transplanton May 13, 2024 at 9:43 am
Arthur Gillespie successfully had a double lung transplant after nearly four years of struggling with cancer and COVID damage.
- A blood test to help detect lung cancer? New test offered at 18 locationson May 13, 2024 at 8:50 am
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she'd ever found time to do.
- FDA Speeds Up Review of Novel Small Cell Lung Cancer Drugon May 13, 2024 at 6:00 am
The Food and Drug Administration will speed up its review of SNB-101 to treat patients with small cell lung cancer.
via Bing News